![Melissa Rhodes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Rhodes
Operationeel Directeur bij Avalyn Pharma, Inc.
Profiel
Melissa Rhodes currently works at The North Carolina Museum of Life & Science, Inc., as Director and Avalyn Pharma, Inc., as Chief Operating Officer from 2023.
Dr. Rhodes received her doctorate degree from Duke University Medical Center.
Actieve functies van Melissa Rhodes
Bedrijven | Functie | Begin |
---|---|---|
The North Carolina Museum of Life & Science, Inc.
![]() The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services The North Carolina Museum of Life & Science, Inc. operates museums and exhibitions. The company was founded in 1946 and is headquartered in Durham, NC. | Directeur/Bestuurslid | - |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Operationeel Directeur | 11-09-2023 |
Opleiding van Melissa Rhodes
Duke University Medical Center | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
The North Carolina Museum of Life & Science, Inc.
![]() The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services The North Carolina Museum of Life & Science, Inc. operates museums and exhibitions. The company was founded in 1946 and is headquartered in Durham, NC. | Consumer Services |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |